That was the year that was
December 4, 2025
Qinecsa Chief Product Officer, Beena Wood, has been featured in Pharma Time’s latest issue, where she reflects on the importance of groundwork before forging ahead
Qinecsa Chief Product Officer, Beena Wood, has been featured in Pharma Time’s latest issue, where she reflects on the importance of groundwork before forging ahead
When Aurinia Pharmaceuticals launched their first FDA-approved product, LUPKNIS© (voclosporin), they recognised the need for a modern, scalable PV infrastructure. Reportum© was deployed which has
A global top-5 pharmaceutical company launched a groundbreaking therapy in one of it’s largest markets. Due to the success of the blockbuster drug, the team
Our client; a top-50 holistic healthcare company headquartered in Japan, globally markets several pharmaceuticals and nutraceuticals. Their challenge included processing cases from local affiliates worldwide
Qinecsa VP, Product Management QVW, Jon Messer, has been featured in European Pharmaceutical Contractor’s latest issue, where he discusses that using statistical methods in signal
Qinecsa Chief Operating Officer, John Cogan, has been featured in Chimica Oggi Chemistry Today’s latest issue, where he discusses the impact of new therapy areas
Qinecsa VP Product Management QVW, Jonathan Messer, has been featured in Drug Discovery World’s latest issue, where he discusses that the rise in global regulatory
Qinecsa COO, John Coganr, has been featured in The Journal of mHealth’s latest issue, where he discusses that small pharma companies don’t need state-of-the-art systems
Qinecsa COO, John Cogan, has been featured in The Pharma Navigator’s latest issue, where he discusses that increasing the use of advanced technologies will support
Qinecsa COO, John Cogan, has been featured in Pharmaceutical Outsourcing’s latest issue, where he discusses why adverse event case processing is an enormous cost center